Reduction in gross profit for April was due to revising the ongoing costs of the business.
Page 7 of todays presentation: “CostBase–has been revised+25% to circa $11.0mpa(from$8.75m) to include additional new product initiatives and allow us to capture further revenue generating opportunities”
Full year EBITDA forecast still $10.7m, so still looks good.
Ann: Appendix 4C H1 Q2 2019, page-11
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)